Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | IDE | P14735 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16366910 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL565778 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL13165092 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL565342 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL309059 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10044329 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10140187 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL10140259 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL309816 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 | |
| SCHEMBL1270218 | 1.00 | TDP1 (0.62) | TDP1PLCD1CNR1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119414015-A | Universal anti-AAV 9 antibody ELISA kit and detection method of anti-AAV 9 antibody thereof | 浙江恒驭生物科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118006733-B | Nucleic acid chemiluminescence detection method based on Cas12a and streptavidin aptamer cascade | 艾特生物科技(深圳)有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118006733-A | Nucleic acid chemiluminescence detection method based on Cas12a and streptavidin aptamer cascade | 艾特生物科技(深圳)有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117783531-A | Mycotoxin fluorescent probe based on quantum dots and application thereof | 河南工业大学 | 2024-03-29 | — | — | CN | claimed |
| US-20260133154-A1 | ELECTROCHEMICAL SHOTGUN TAGGING ASSAY WITH CATALYTIC AMPLIFICATION | OXFORD UNIV INNOVATION LIMITED (GB) | 2026-05-14 | — | — | US | disclosed |
| US-20260126440-A1 | METHODS FOR MEASURING LYMPHOCYTE ACTIVITY | KITE PHARMA INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4725560-A2 | ANTI-B7H3 ANTIBODIES FOR THE PREPARATION OF ANTIBODY DRUG CONJUGATES (ADCS) OF KSP INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-20250243540-A1 | PROBE RELATED REAGENTS AND METHODS | BRENTANO BIOTECHNOLOGY ASSOCIATES (US) | 2025-07-31 | — | — | US | disclosed |
| CN-119738564-A | Universal anti-AAV 8 antibody ELISA kit and detection method of anti-AAV 8 antibody thereof | 浙江恒驭生物科技有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119555930-A | Photo-activated chemiluminescence detection reagent composition, kit, detection method and device | 科美诊断技术股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119510773-A | Lentivirus titer detection kit and detection method | 浙江恒驭生物科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20250052745-A1 | COMPOSITION, METHOD AND KIT FOR PATHOLOGY | RUNGE RICHARD (US) | 2025-02-13 | — | — | US | disclosed |
| US-20120177573-A1 | METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120045784-A1 | BIOTINIDASE ASSAY | Joachim Ngiamas trustee for Joachim Ngiam Trust Fund ABN | 2012-02-23 | — | — | US | disclosed |
| WO-2010106222-A2 | BIOTINIDASE ASSAY | WALLAC OY (FI) | 2010-09-23 | — | — | WO | disclosed |
| US-20090124562-A1 | Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent | TOUDAI TLO, LTD. (JP) | 2009-05-14 | — | — | US | disclosed |
| US-20090124562-A1 | Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent | TOUDAI TLO, LTD. (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1145006-B1 | DETECTION OF SMALL MOLECULES BY USE OF A PIEZOELECTRIC SENSOR | YISSUM RES DEV CO (IL) | 2008-03-19 | — | — | EP | disclosed |
| US-20070087383-A1 | Immunoassay | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2007-04-19 | — | — | US | disclosed |
| US-20070087383-A1 | Immunoassay | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124562-A1 | Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent | HSPA4, GRPR, HSPA5 | TDP1 2286/4885PLCD1 4228/4885CNR1 4208/4885 |
| US-20120177573-A1 | METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES | RNGTT, POLM, POLRMT | TDP1 189/4885PLCD1 639/4885CNR1 4602/4885 |
| US-20260126440-A1 | METHODS FOR MEASURING LYMPHOCYTE ACTIVITY | CD14, CD47, CD4 | TDP1 3641/4885PLCD1 2058/4885CNR1 1008/4885 |
| US-20250243540-A1 | PROBE RELATED REAGENTS AND METHODS | DNTT, NCL, NT5C3B | TDP1 730/4885PLCD1 2095/4885CNR1 1764/4885 |
| US-20260133154-A1 | ELECTROCHEMICAL SHOTGUN TAGGING ASSAY WITH CATALYTIC AMPLIFICATION | BTD, APEX1, ACP1 | TDP1 252/4885PLCD1 2990/4885CNR1 2571/4885 |
| US-20120045784-A1 | BIOTINIDASE ASSAY | BTD, CMBL, JMJD7 | TDP1 2853/4885PLCD1 3746/4885CNR1 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.